Table 6. Effect of TMZ treatment during the RAHF phase (lean luteal females) (n = 6).

Treatment group	Heart rate (%)	Sig.	LVDevP (%)	Sig.
Control	33.55 ± 4.86	ns	6116.62 ± 1675.88	ns
TMZ at CAHF	34.18 ± 5.60		6202.00 ± 1064.64
TMZ at RAHF	27.31 ± 1.41		9475.80 ± 1807.90
Treatment group	LVEDP (%)	Sig.	LVESP (%)	Sig.
Control	179.64 ± 10.82	ns	199.59 ± 13.44	ns
TMZ at CAHF	176.24 ± 43.51		194.08 ± 51.29
TMZ at RAHF	134.06 ± 4.27		147.00 ± 6.88

Data represent the last ten minutes of the RAHF phase and is expressed as a percentage of CAHF. LVDevP: left ventricular developed pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; CAHF: critical acute heart failure; RAHF: recovery acute heart failure; Sig.: significance; ns: not significant.